Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies
Open Access
- 13 November 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1418131
Abstract
Bladder cancer (BC) is the ninth most common and “expensive” cancer in the world. Despite the availability of various treatment modalities such as chemotherapy, immunotherapy and surgery, the overall survival rate of patients with advanced bladder cancer remains low. As one of the most abundant infiltrating immune cells in bladder cancer, tumor-associated macrophages (TAMs) play an important role in the development of BC and in the standard regimen of intravesical BCG therapy. Targeting TAMs have achieved excellent results in clinical trials for a variety of other cancers, but few studies have been conducted for bladder cancer. Further exploration is still needed to develop TAM-related therapeutic strategies for BC treatment, which are expected to improve the therapeutic efficacy and life quality of patients. This review summarizes the relationship between TAMs in bladder cancer and disease staging, evolution, patient prognosis, and treatment outcome. Several potential TAM targets in BC are also pointed, which may help to inhibit tumor-promoting TAMs and provide new therapeutic approaches for advanced BC.Keywords
This publication has 125 references indexed in Scilit:
- Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interactionCell Communication and Signaling, 2018
- Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase InhibitionFrontiers in Immunology, 2018
- Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic MelanomaFrontiers in Immunology, 2018
- Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa StudyLeukemia, 2017
- Interplay between VEGF and Nrf2 regulates angiogenesis due to intracranial venous hypertensionScientific Reports, 2016
- Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer PatientsCancer Cell, 2016
- Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21Blood, 2015
- Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancerJournal of Experimental & Clinical Cancer Research, 2013
- Contribution of CXCL12 secretion to invasion of breast cancer cellsBreast Cancer Research, 2012
- Tumour macrophages as potential targets of bisphosphonatesJournal of Translational Medicine, 2011